Table 4.

Cox Model Analysis For The Correlation Between IFIT2 Expression Level In Lung Squamous Cell Carcinoma And Patients’ Clinical Parameters

Clinical Parameters	Univariate Analysis		Multivariate Analysis
HR (95% CI)	P	HR (95% CI)	P
Gender (M/F)	1.784 (0.242~13.138)	0.533	1.103 (0.130~9.363)	0.928
Age (≥60/<60)	1.830 (0. 818~4.095)	0.141	1.552 (0.627~3.840)	0.342
Tumor diameter (≥4.5 cm/<4.5 cm)	0.947 (0.470~1.907)	0.878	0.859 (0.336~2.200)	0.752
Tumor stage (T3~T4/T1~T2)	1.142 (0.704~3.037)	0.309	1.851 (0.642~5.339)	0.255
Lymph node metastasis (Yes/No)	3.201 (1.511~6.780)	0.002	3.390 (1.029~11.175)	0.045
TNM stage (III~IV/I~II)	0.878 (0.612~1.260)	0.480	1.203 (0.334~4.328)	0.777
IFIT2 (Low/High)	2.907 (1.118~7.559)	0.029	3.762 (1.236~11.451)	0.020

Note: Bold signifies P<0.05.

Abbreviation: IFIT2, interferon-induced proteins with tetratricopeptide repeats 2.